Globus Medical (GMED) Tops Q4 EPS by 7c, FY Guidance Falls Short of Consensus

Globus Medical (NYSE: GMED) reported Q4 EPS of $0.58, $0.07 better than the analyst estimate of $0.51. Revenue for the quarter came in at $233.4 million versus the consensus estimate of $231.22 million.

GUIDANCE:

Globus Medical sees FY2021 EPS of $1.83, versus the consensus of $2.01. Globus Medical sees FY2021 revenue of $880 million, versus the consensus of $914.2 million.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• Worried the AI trade has gone too far? Evercore likes these 4 stocks